VT Bio Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
VT Bio General Information
Description
Operator of a biotechnology company intended to develop new drugs to improve the quality of life for COPD (Chronic obstructive pulmonary disease) patients. The company offers therapies, medicines, and hair care products for dementia, depression, chronic obstructive pulmonary disease, diabetes, hair loss, hair growth, and the liver, among others, enabling individuals to improve the quality of life and welfare of mankind through aggressive commercialization.
Contact Information
Website
www.vtbio.co.krCorporate Office
- 301, 16, Samseong-ro 76-gil
- Gangnam-gu
- Seoul
- South Korea
Corporate Office
- 301, 16, Samseong-ro 76-gil
- Gangnam-gu
- Seoul
- South Korea
VT Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Jul-2025 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Jan-2018 | Completed | Generating Revenue | |||
| 1. Seed Round | Completed | Startup |
VT Bio Patents
VT Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4403179-A1 | Pharmaceutical composition containing regulatory t cells as active ingredient for preventing or treating degenerative brain diseases | Inactive | 13-Sep-2021 | ||
| EP-4403179-A4 | Pharmaceutical composition containing regulatory t cells as active ingredient for preventing or treating degenerative brain diseases | Inactive | 13-Sep-2021 | ||
| US-20240293542-A1 | Pharmaceutical composition containing regulatory t cells as active ingredient for preventing or treating degenerative brain diseases | Pending | 13-Sep-2021 | ||
| WO-2023038489-A1 | Pharmaceutical composition containing regulatory t cells as active ingredient for preventing or treating degenerative brain diseases | Inactive | 13-Sep-2021 | ||
| JP-2024535130-A | Pharmaceutical composition for preventing or treating degenerative brain diseases containing regulatory t cells as an active ingredient | Pending | 13-Sep-2021 | A61K35/17 |
VT Bio Signals
VT Bio FAQs
-
When was VT Bio founded?
VT Bio was founded in 2000.
-
Where is VT Bio headquartered?
VT Bio is headquartered in Seoul, South Korea.
-
What is the size of VT Bio?
VT Bio has 3 total employees.
-
What industry is VT Bio in?
VT Bio’s primary industry is Biotechnology.
-
Is VT Bio a private or public company?
VT Bio is a Private company.
-
What is VT Bio’s current revenue?
The current revenue for VT Bio is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process